We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Jounce Therapeutics Inc | NASDAQ:JNCE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.88 | 2.00 | 1.79 | 0 | 01:00:00 |
Delaware
|
|
001-37998
|
|
45-4870634
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
1030 Massachusetts Avenue
Cambridge, Massachusetts
|
|
02138
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Emerging growth company
|
x
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press release issued by the Company on May 9, 2017
|
|
JOUNCE THERAPEUTICS, INC.
|
|
|
|
|
Date: May 9, 2017
|
By:
|
/s/ Kim C. Drapkin
|
|
|
Kim C. Drapkin
|
|
|
Treasurer and Chief Financial Officer
|
1 Year Jounce Therapeutics Chart |
1 Month Jounce Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions